Fibrinolytic and antithrombotic therapy theory, practice, and management /
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Searvvušdahkki: | |
| Eará dahkkit: | |
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Oxford ; New York :
Oxford University Press,
2006.
|
| Preanttus: | 2nd ed. |
| Fáttát: | |
| Liŋkkat: | An electronic book accessible through the World Wide Web; click to view |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Sisdoallologahallan:
- Historical perspectives in hemostasis, coagulation and fibrinolysis
- Vascular biology, thromboresistance and inflammation
- Atherosclerosis and arterial thrombosis
- Venous thromboembolism
- Cardiac chamber, aortic and valvular thromboembolism
- Fibrinolytic agents
- Aspirin
- Clopidogrel
- Platelet Glycoprotein IIb/IIIa receptor antagonists
- Aggrenox and cilostazol
- Novel platelet antagonists
- Combination pharmacotherapy
- Facilitated percutaneous coronary intervention
- Thrombin-directed therapy
- Factor Xa inhibitors
- Direct thrombin inhibitors
- Novel anticoagulants
- Acute coronary syndromes
- Peripheral vascular disease and stroke
- Valvular heart disease and atrial fibrillation
- Plaque-stabilizing therapies
- Venous thromboembolism prophylaxis
- Venous thromboembolism treatment
- Fundamentals and patient evaluation
- Platelet antagonists
- Anticoagulants
- Anticoagulation clinics and self-testing
- Platelet antagonists
- Anticoagulants
- Fibrinolytic agents.